Incyte (INCY) Gross Profit (2012 - 2026)
Incyte's (INCY) quarterly Gross Profit came in at $1.6 billion in Q2 2026, up 38.03% YoY from $1.1 billion in Q2 2025, and up 34.32% on a QoQ basis from $1.2 billion in Q1 2026.
Incyte (INCY) Gross Profit (2012 - 2026) Analysis & Trends
Incyte (INCY) has 15 years of Gross Profit data on file, last reported at $1.6 billion in Q2 2026.
- Quarterly Gross Profit rose 38.03% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.4 billion (up 26.57% YoY) and the FY2025 annual result came in at $4.8 billion, up 21.38% from the prior year.
- Gross Profit improved to $1.6 billion in Q2 2026, from $1.2 billion in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $1.6 billion in Q2 2026 to a low of $690.6 million in Q1 2022.
- A 5-year average of $1.0 billion and a median of $955.4 million in 2023 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit slipped 0.57% — and 2026, when it jumped 38.03%.
- Tracing INCY's Gross Profit over 5 years: stood at $867.5 million in 2022, then increased by 8.77% to $943.6 million in 2023, then gained by 15.54% to $1.1 billion in 2024, then climbed by 27.1% to $1.4 billion in 2025, then grew by 13.24% to $1.6 billion in 2026.
- The last three Gross Profit figures came in at $1.6 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Incyte | 24.15 Bn | 19.61 Bn | 1.57 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57 Bn |
| Jun 30, 2026 | 1.57 Bn |
| Mar 31, 2026 | 1.17 Bn |
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 1.27 Bn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 979.71 Mn |
| Mar 31, 2025 | 979.71 Mn |
| Dec 31, 2024 | 1.09 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 967.13 Mn |
| Jun 30, 2024 | 967.13 Mn |
| Mar 31, 2024 | 819.93 Mn |
| Mar 31, 2024 | 819.93 Mn |